Industries > Pharma > Synthetic Biology Market Report 2022-2032

Synthetic Biology Market Report 2022-2032

Product Type (Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Synthetic Genes, Synthetic Clones, Chassis Organisms, Xeno-Nucleic Acids, Other), by Technology (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mutagenesis, Measurement & Modelling, Microfluidics, Nanotechnology, Other), by Application (Medical & Pharmaceutical Applications (Drug Discovery and Therapeutics (Cancer Detection & Diagnostics, Other), Artificial Tissue & Tissue Regeneration (Bio-Synthesis, Stem Cell Regulation, Other), Industrial Applications, Biofuel and Renewable Energy, Industrial Enzymes (Textile Industry, Paper Industry, Other), Biomaterials & Green Chemicals, Food & Agriculture, Environmental Applications (Bioremediation, Biosensing), Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

PUBLISHED: 27 July 2022
PAGES: 745
PRODUCT CODE: PHA1009
SUBMARKET: Biotechnology

Clear
WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1009 Categories: , Tag:

The Synthetic Biology Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing R&D in Biotechnological and Pharmaceutical Businesses
The growing demand for synthetic biology in biotechnological and pharmaceutical research and development leads to the growth of this industry. For example, the pharmaceutical research-based business spends about 149.8 billion USD each year on R&D, according to the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). Organisms and engineered networks for disease-mechanism elucidation, drug-discovery platforms, drug-target identification, therapeutic delivery, therapeutic treatment, and drug manufacture are examples of synthetic biology contributions to the field of therapeutic. The synthetic biology industry is likely to increase significantly in the near future due to rising demand for medicinal applications.

Environment Safety Challenges May Restrict The Adoption of Synthetic Biology Up to Certain Extent
The deliberate or unintentional introduction of synthetic organisms into the environment during research and other applications poses a significant biosafety issue in synthetic biology. Synthetic bacteria can mutate or interact with other species in the environment, leading in crossbreeding and bio errors. This has the potential to threaten the environment of wild creatures. The emergence of antibiotic-resistant superbugs is another key biosafety worry. In recent years, the European Union (EU) has funded a number of research studies investigating the environmental impact of genetically modified bacteria purposely released for plant growth or bioremediation. However, biosafety, biosecurity, and ethical risks associated with synthetic biology may stymie business growth.

What Questions Should You Ask before Buying a Market Research Report?
• How is the synthetic biology market evolving?
• What is driving and restraining the synthetic biology market?
• How will each synthetic biology submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each synthetic biology submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading synthetic biology markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the synthetic biology projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implications of synthetic biology projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the synthetic biology market?
• Where is the synthetic biology market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the synthetic biology market today, and over the next 10 years:
• Our 745-page report provides 355 tables and 710 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the synthetic biology market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

The report delivers exclusive COVID-19 variations and economic data specific to your market.

To access the data contained in this document please email contactus@visiongain.com

Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising synthetic biology prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product Type Outlook
• Oligonucleotides & Synthetic DNA
• Enzymes
• Cloning Technology Kits
• Synthetic Cells
• Synthetic Genes
• Synthetic Clones
• Chassis Organisms
• Xeno-Nucleic Acids
• Other Product Types

Technology Outlook
• Gene Synthesis
• Genome Engineering
• Sequencing
• Bioinformatics
• Cloning
• Site-Directed Mutagenesis
• Measurement & Modeling
• Microfluidics
• Nanotechnology
• Other Technologies

Application Outlook

• Medical & Pharmaceutical Applications
– Drug Discovery and Therapeutics (Cancer Detection & Diagnostics, Other Drug Discovery and Therapeutic Applications)
– Artificial Tissue & Tissue Regeneration (Bio-Synthesis, Stem Cell Regulation, Other Artificial Tissue and Tissue Regeneration Applications)

• Industrial Applications
– Biofuel and Renewable Energy
– Industrial Enzymes (Textile Industry, Paper Industry, Other Industries)
– Biomaterials & Green Chemicals

• Food & Agriculture

• Environmental Applications
– Bioremediation
– Biosensing

• Other Applications

Operation
• Preclinical
• Clinical
• Commercial
• Other Operations

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America

Middle East & Africa
• Turkey
• Saudi Arabia
• South Africa
• UAE
• Egypt
• Rest of Middle East & Africa

Synthetic Biology Market Report 2022-2032
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the Synthetic Biology Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Amyris Inc.
• Agilent Technologies Inc.
• Codexis, Inc.
• Danaher Corporation
• ElevateBio
• Genscript Biotech Corporation
• Ginkgo Bioworks
• GRO Biosciences
• Merck KGaA
• New England Biolabs
• Precigen Inc.
• Synthetic Genomics (Viridos)
• Synlogic
• Twist Bioscience Corp.
• Thermo Fisher Scientific Inc.

Overall world revenue for Synthetic Biology Market, 2022 to 2032 in terms of value the market will surpass US$16.9 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Synthetic Biology Market, 2022 to 2032 report help you?
In summary, our 740+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Synthetic Biology Market, 2022 to 2032 Market, with forecasts for product type, technology, and application, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2032 for five regional and 20 key national markets – See forecasts for the Synthetic Biology Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, South Africa, UAE and Egypt among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the Synthetic Biology Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Synthetic Biology Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Synthetic Biology Market Report 2022-2032: Product Type (Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Synthetic Genes, Synthetic Clones, Chassis Organisms, Xeno-Nucleic Acids, Other), by Technology (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mutagenesis, Measurement & Modelling, Microfluidics, Nanotechnology, Other), by Application (Medical & Pharmaceutical Applications (Drug Discovery and Therapeutics (Cancer Detection & Diagnostics, Other), Artificial Tissue & Tissue Regeneration (Bio-Synthesis, Stem Cell Regulation, Other), Industrial Applications, Biofuel and Renewable Energy, Industrial Enzymes (Textile Industry, Paper Industry, Other), Biomaterials & Green Chemicals, Food & Agriculture, Environmental Applications (Bioremediation, Biosensing), Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Synthetic Biology Market Report 2022-2032


Download sample pages

Complete the form below to download your free sample pages for Synthetic Biology Market Report 2022-2032


Latest Pharma news

Visiongain Publishes Genome Editing Technologies Market Report 2022-2032

The Global Genome Editing Technologies market is estimated to be valued at US$ 4,225.48 million in 2022. The market is projected to reach a market value of US$ 18,570.41 million by 2032. We predict strong revenue growth through to 2032.

02 August 2022

READ

Visiongain Publishes Synthetic Biology Market Report 2022-2032

The global synthetic biology market was valued at US$13.8 billion in 2021 and is projected to grow at a CAGR of 25.52% during the forecast period 2022-2032.

27 July 2022

READ

Visiongain Publishes Biosimilar Monoclonal Antibodies Market Report 2022-2032

The global biosimilar monoclonal antibodies market was valued at US$4,087 million in 2021 and is projected to grow at a CAGR of 23.5% during the forecast period 2022-2032.

25 July 2022

READ

Visiongain Publishes Drug Discovery Services Market Report 2022-2032

The global drug discovery services market is anticipated to be valued at US$14.17 billion in 2022 and is projected to grow at a CAGR of 15.17% during the forecast period 2022-2032.

20 July 2022

READ